Reye's Syndrome & Aspirin
BMJ 292:1543-1544, 15901986., Tarlow,M., 1986
No Effect of Acetylsalicylic Acid on B-Thromboglobulin & Platelet Factor 4 Plasma Levels in Patients with TIA's
Stroke 17:1153-1155, Carrieri,P.,et al, 1986
The Clinical Spectrum of Hemorrhagic Infarction
Stroke 17:630-637, Ott,B.R.,et al, 1986
Hemorrhagic Infarcts
Stroke 17:586-589, Hart,R.G.&Easton,D., 1986
Aspirin:What Dose? Editorial
Lancet 1:592-593, , 1986
Cardiogenic Brain Embolism
Cerebral Embolism Task Force, Arch Neurol 43:71-841986., , 1986
The Secondary Prevention of Stroke in Patients with Atrial Fibrillation
Arch Neurol 43:66-68, 701986., Starkey,I.&Warlow,C., 1986
The Secondary Prevention of Stroke in Patients with Atrial Fibrillation
Arch Neurol 43:68-70, Sherman,D.G.,et al, 1986
Treatment of Acute Ischemic Stroke, Open Trial with Continuous Intravenous Heparinization
Arch Neurol 43:386-390, Ramirez-Lassepas,M.,et al, 1986
Hemorrhagic Complications of Long-Term Anticoagulant Therapy for Ischemic Cerebral Vascular Disease
Stroke 17:111-116, Levine,J.&Hirsh,J., 1986
Dissections
Stroke 16:925-927, Hart,R.G.&Easton,J.D., 1985
Public Health Service Study on Reye's Syndrome & Medications, Report of the Pilot Phase
NEJM 313:849-857, Hurwitz,E.S.,et al, 1985
Naproxen in Prophylaxis of Migraine
Arch Neurol 42:582-584, Ziegler,D.K.,et al, 1985
Vertebrobasilar Insufficiency, A Review
Arch Neurol 42:803-808, Ausman,J.I.,et al, 1985
Persantine Aspirin Trial in Cerebral Ischemia Part II:Endpoint Results
The American-Canadian Co-Operative Study Group, Stroke 16:406-4151985., , 1985
Usefulness of Heparin in Initial Management of Patients with Recent Transient Ischemic Attacks
Arch Neurol 42:960-962, Putman,S.F.&Adams,H.P., 1985
Does Platelet Antiaggregant Therapy Lessen the Severity of Stroke
Neurol 35:632-636, Grotta,J.C.,et al, 1985
Stroke, The Use & Overuse of Heparin in Therapeutic Trials
Arch Neurol 42:315-317, Sage,J.I., 1985
Anticoagulant-Related Intracerebral Hemorrhage
Neurol 35:943-948, Kase,C.S.,et al, 1985
Spontaneous Dissecting Aneurysms of the Internal Carotid & Vertebral Arteries-Two Case Reports
Stroke 16:125-129, Mas,J.,et al, 1985
Stroke Due to Vertebral Artery Injury
Arch Neurol 42:242-248, Katirji,M.B.,et al, 1985
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984
Thromboembolism in Patients with Atrial Fibrillation
Arch Neurol 41:708-710, Sherman,D.G.,et al, 1984
Cerebral Ischemia & Atrial Fibrillation:Prospective Study
Neurol 34:1285-1291, Kelley,R.E.,et al, 1984
Immediate Anticoagulation of Embolic Stroke:Brain Hemorrhage & Management Options
Cerebral Embolism Study Group, Stroke 15:779-7891984., , 1984
Nonseptic Cerebral Emboli of Cardiac Origin
Arch Int Med 144:1997-1999, Martin,G.J.,et al, 1984
Reye's Syndrome Associated with Long-Term Aspirin Therapy
JAMA 251:754-756, Young,R.S.K.,et al, 1984
Anticoagulant-Related Hemorrhage in Acuit Cerebral Embolism
Stroke 15:426-437, Shields,R.W.,et al, 1984
Heparin Therapy for Stroke:Hemorrhagic Complications & Risk Factors for Intracerebral Hemorrhage
Neurol 34:114-117, Ramirez-Lassepas,M.,et al, 1984
Mitral Valve Prolapse & Cerebral Ischemic Events in Young Patients
Neurol 34:784-787, Jackson,A.C.,et al, 1984
Femoral Nerve Dysfunction after Retroperitoneal Hemorrhage:Pathophys by CT
ARch Phys Med Rehabil 65:37-40, Reinstein,A.C.,et al, 1984
Aortic Saddle Embolus, A Twenty-Year Experience
Ann Surg 197:698-706, Busuttil,R.W.,et al, 1983
Neurological Complications of Acquired Immune Deficiency Syndrome:Analysis of 50 Patients
Ann Neurol 14:403-418, Snider,W.D.,et al, 1983
Neurologic Manifestations of Essential Thrombocythemia
Ann Int Med 99:513-518, Jabaily,J.,et al, 1983
Treatment after Transient Ischemic Attacks:A Comparison between Anticoagulant Drug & Inhibition of Platelet Aggrega
Stroke 14:677-681, Garde,A.,et al, 1983
"AICLA"Controlled Trial of Aspirin & Dipyridamole in the Prevention of Athero-Thrombotic Cerebral Ischemia
Stroke 14:5-14, Bousser,M.G.,et al, 1983
Acetylsalicylic Acid in the Prevention of Strokes in Patients with Reversible Cerebral Ischemic Attacks
Stroke 14:15-22, Sorensen,P.S.,et al, 1983
Heparin for Lacunar Stroke in Progression
Stroke 14:421-423, Dobkin,B.H., 1983
Evaluation of the Risk of Immediate Anticoag. Treatment in Patients with Embolic Stroke of Cardiac Origin
Stroke 14:42-46, Lodder,J.,et al, 1983
Conversion of Ischemic to Hemorrhagic Infarction by Anti-coagulant Administration
Arch Neurol 40:44-46, Drake,M.E.,et al, 1983
Incidence & Treatment of Peripheral Venous Thrombosis in Patients with Glioma
Ann Neurol 13:334-336, Ruff,R.L.,et al, 1983
Hepatic & Cerebral Pathology Findings in Children with Fatal Salicylate Intoxication
Lancet 1:326-329, Starko,K.M.,et al, 1983
Immediate Anticoagulation of Embolic Stroke:A Randomized Trial
Stroke 14:668-676, Hakim,A.M.,et al, 1983
Sequential Computerized Tomographic Appearance of Strokes
Stroke 14:893-897, Hakim,A.M.,et al, 1983
Carbamazepine & Hematological Monitoring
Ann Neurol 11:309-312, Hart,R.G.,et al, 1982
Aspirin as a Risk Factor in Reye's Syndrome
JAMA 247:3089-3094, Waldman,R.J.,et al, 1982
Reye's Syndrome & Medication Use
JAMA 248:687-691, Halpin,T.J.,et al, 1982
Recurrent Embolic Cerebral Infarction & Anticoagulation
Neurol 32:283-285, Koller,R.L., 1982
Hemorrhage & Anticoagulation After Nonseptic Embolic Brain Infarction
Neurol 32:280-282, Furlan,A.J.,et al, 1982
Serum Salicylate Concentrations In Reye's Disease
Lancet 1:191-193, Partin,J.S.,et al, 1982